Dhanir Tailor

Oregon Health & Science University — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

12h-index647citations75works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ubiquitin and proteasome pathways(10), Cancer, Hypoxia, and Metabolism(8), Cancer, Lipids, and Metabolism(6), RNA Research and Splicing(5), Natural product bioactivities and synthesis(5)

Publications75 total

One-Pot Gateway to Quinazoline–Thiohydantoin Fused Scaffolds and Discovery of Their Antileukemic Activity
JACS Au·2026Open Access
Uncovering functional divergence and cellular clusters with specific gene signatures in HNSCC clonal spheroids
Cell Communication and Signaling·2025Open Access
Non-orthosteric inhibition of enolase 1 impedes growth of triple-negative breast cancer
Cell Reports Medicine·2025Open Access
Novel Aza-podophyllotoxin Derivative Inhibits Growth of Triple-Negative Breast Cancer
ACS Omega·2025Open Access
Designing Cyclic Nitrogen‐Bridged Sulfonamides with Anti‐Cancer Activity
ChemMedChem·2025Open Access
Abstract 6879: Inhibition of triple-negative breast cancer progression via ribosomal protein(s) modulation
Cancer Research·2025
Abstract 7007: Identifying novel non-allosteric PIM1 degraders to overcome treatment resistance in triple negative breast cancer
Cancer Research·2025
Abstract 4292: Targeting YB-1 as a treatment strategy for high-grade serous ovarian carcinoma
Cancer Research·2025
Mycobacterium w - a promising immunotherapeutic intervention for diseases
Frontiers in Immunology·2024· 2 citedOpen Access
Uncovering therapeutic targets for macrophage-mediated T cell suppression and PD-L1 therapy sensitization
Cell Reports Medicine·2024· 10 citedOpen Access
MDB-104. TARGETING Y BOX BINDING PROTEIN (YBX1) IN PEDIATRIC MEDULLOBLASTOMA
Neuro-Oncology·2024Open Access
Clonal spheroids capture functional and genetic heterogeneity of head and neck cancer
2024Open Access
Inhibition of protein translational machinery in triple-negative breast cancer as a promising therapeutic strategy
Cell Reports Medicine·2024· 21 citedOpen Access
Abstract 5926: YB-1 inhibition as an effective approach for the treatment of osteosarcoma
Cancer Research·2024· 1 cited
Abstract 4617: Fisetin, a multi-kinase inhibitor enhances chemotherapeutic sensitivity in head and neck cancer
Cancer Research·2024· 2 cited
Abstract 5935: Non-allosteric inhibition of enolase 1 sensitizes triple-negative breast cancer for checkpoint inhibitors
Cancer Research·2024
Abstract 5933: Identifying MC4R-targeted small molecule to investigate MC4R impact on cachexia progression
Cancer Research·2024
Abstract 561: Targeting Y box binding protein 1 (YBX1) in <i>MYC-</i>amplified medulloblastoma
Cancer Research·2024
Abstract 668: Enhancing chemosensitivity of lung adenocarcinoma via Y-box binding protein 1 (YB-1) inhibition
Cancer Research·2024
Abstract 7151: Targeting metabolic pathway in triple negative breast cancer with a small molecule inhibitor
Cancer Research·2024
page 1 of 4Next →

Frequent Co-authors

Sanjay V. Malhotra(37), Arpit Dheeraj(22), Rana P. Singh(14), Mallesh Pandrala(12), Sharon J. Pitteri(12), Abel Bermudez(10), Fernando Jose Garcia-Marques(8), Bakulesh Khamar(7), Angel Resendez(6), Kirsten Stefan(6), Alexander Honkala(5), Dhanya K. Nambiar(5), Catherine C. Going(5), Saloni Gupta(5), Tanya Stoyanova(4), Anna P. Hnatiuk(4), Arne A.N. Bruyneel(4), Wenqi Li(4), Ricardo Serrano(4), Dries Feyen(4)